Mike Train at the NBIRT Life Science Event in Dublin earlier in 2017. |
“Our extensive experience in the life sciences industry and integrated offering for capital projects and automation perfectly positions us to help Novo Nordisk deliver its largest project in history,” said Mike Train, executive president, Emerson Automation Solutions. “Together we can design and deliver this world-class manufacturing facility to be ready on time, and to quickly bring these important diabetes medicines to patients.”
Novo Nordisk will implement elements of Emerson’s Project Certainty approach to help reduce project complexity and achieve the tight project schedule. This transformational approach leverages automation technology, which serves as a central nervous system in a plant, and new methodologies, to reduce costs and complexity and accommodate late-stage project changes.
Novo Nordisk selected Emerson’s integrated portfolio of automation technologies and services, including its DeltaV™ distributed control system (DCS) and Syncade manufacturing execution system (MES). Emerson will also provide smart automation technologies including valves and measurement instrumentation.
@EMR_Automation #PAuto #LifeScience @Emerson_News @HHC_Lewis
No comments:
Post a Comment